Forget 2025: 2 Growth Stocks Poised to Soar in 2026

jueves, 29 de enero de 2026, 5:57 am ET1 min de lectura
DKNG--
RXRX--

Two growth stocks, DraftKings and Recursion Pharmaceuticals, are expected to recover in 2026 after experiencing pullbacks in 2025. DraftKings' brand name and partnerships with NBCUniversal and ESPN are seen as promotional opportunities that will help it overcome competition from prediction-market platforms. Recursion Pharmaceuticals' AI-powered drug discovery platform, Recursion OS, has the potential to prove its premise in 2026, offering a promising recovery rally.

Forget 2025: 2 Growth Stocks Poised to Soar in 2026

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios